Top compounds associated with response to NUDT17


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.12 0.003
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA myriocin CTRPv2 pan-cancer AAC -0.24 0.003
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA BHG712 GDSC1000 pan-cancer AAC -0.088 0.004
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.11 0.004
Download CSV